Your browser doesn't support javascript.
loading
α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of Melicope latifolia bark extracts and identification of bioactive constituents using in vitro and in silico approaches.
Quek, Alexandra; Kassim, Nur Kartinee; Lim, Pei Cee; Tan, Dai Chuan; Mohammad Latif, Muhammad Alif; Ismail, Amin; Shaari, Khozirah; Awang, Khalijah.
Affiliation
  • Quek A; Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
  • Kassim NK; Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
  • Lim PC; Integrated Chemical BioPhysics Research, Faculty of Science, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
  • Tan DC; Faculty of Pharmacy, Mahsa University, Bandar Saujana Putra, Jenjarom, Selangor, Malaysia.
  • Mohammad Latif MA; Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
  • Ismail A; Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
  • Shaari K; Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
  • Awang K; Natural Medicines & Products Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
Pharm Biol ; 59(1): 964-973, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34347568
ABSTRACT
CONTEXT Melicope latifolia (DC.) T. G. Hartley (Rutaceae) was reported to contain various phytochemicals including coumarins, flavonoids, and acetophenones.

OBJECTIVE:

This study investigates the antidiabetic and antioxidant effects of M. latifolia bark extracts, fractions, and isolated constituents. MATERIALS AND

METHODS:

Melicope latifolia extracts (hexane, chloroform, and methanol), fractions, and isolated constituents with varying concentrations (0.078-10 mg/mL) were subjected to in vitro α-amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory assay. Molecular docking was performed to study the binding mechanism of active compounds towards α-amylase and DPP-4 enzymes. The antioxidant activity of M. latifolia fractions and compounds were determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging and ß-carotene bleaching assays.

RESULTS:

Melicope latifolia chloroform extract showed the highest antidiabetic activity (α-amylase IC50 1464.32 µg/mL; DPP-4 IC50 221.58 µg/mL). Fractionation of chloroform extract yielded four major fractions (CF1-CF4) whereby CF3 showed the highest antidiabetic activity (α-amylase IC50 397.68 µg/mL; DPP-4 IC50 37.16 µg/mL) and resulted in ß-sitosterol (1), halfordin (2), methyl p-coumarate (3), and protocatechuic acid (4). Isolation of compounds 2-4 from the species and their DPP-4 inhibitory were reported for the first time. Compound 2 showed the highest α-amylase (IC50 197.53 µM) and ß-carotene (88.48%) inhibition, and formed the highest number of molecular interactions with critical amino acid residues of α-amylase. The highest DPP-4 inhibition was exhibited by compound 3 (IC50 911.44 µM). DISCUSSION AND

CONCLUSIONS:

The in vitro and in silico analyses indicated the potential of M. latifolia as an alternative source of α-amylase and DPP-4 inhibitors. Further pharmacological studies on the compounds are recommended.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plant Extracts / Rutaceae / Alpha-Amylases / Dipeptidyl-Peptidase IV Inhibitors Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Pharm Biol Year: 2021 Document type: Article Affiliation country: Malaysia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plant Extracts / Rutaceae / Alpha-Amylases / Dipeptidyl-Peptidase IV Inhibitors Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Pharm Biol Year: 2021 Document type: Article Affiliation country: Malaysia